Syndesi Therapeutics

Developer of small molecule for treating Alzheimer's disease

placeLouvain La Neuve, Wallonia, Belgium calendar_todayFounded 2018 groups1 employees language syndesitherapeutics.com

Registered entities

Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 53 times.

YearFilings
20222
20231
20241

Investor mix

7 investors on record; lead investors include Novo Holdings, Fountain Healthcare Partners; 2 have since exited.

Investor typeCountShare
Venture capital457%
Private equity114%
Accelerator & incubator114%
Other / undisclosed114%
Coming soon